INVESTER I OPTOMED OY MED ENDAVU: Køb Optomed Oy ($36U0) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Optomed Oy, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Optomed Plc is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. The company operates in two segments: Devices, which develops, manufactures, and commercializes easy-to-use handheld fundus cameras for screening eye diseases like diabetic retinopathy, glaucoma, and age-related macular degeneration; and Software, which provides AI-powered solutions such as Avenue AI, Avenue Eye Screen, and Avenue Flow for workflow management, telemedicine, and disease monitoring. Notable products include Optomed Smartscope Pro, Aurora, and Polaris brands, alongside OEM cameras for partners like Volk Optical, Carl Zeiss Meditec, and Topcon. Optomed integrates artificial intelligence and explores oculomics to detect systemic conditions via retinal imaging, enhancing early diagnosis in ophthalmology, primary care, and beyond. With over 100 employees, headquarters in Oulu, Finland, and subsidiaries in the US and China, it sells through distributors, OEMs, and direct channels in over 60 countries, playing a pivotal role in making eye screening accessible globally and advancing preventive healthcare through portable, AI-driven diagnostics.